Ally Bridge Group »

First Tracks Biotherapeutics shares owned by Ally Bridge Group

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.7M 284k 20.12

More positions owned by Ally Bridge Group

Definium Therapeutics Com Shs Call Option (DFTX)
Abivax Sa Sponsored Ads Call Option (ABVX)
Minerva Neurosciences Com New (NERV)
Promis Neurosciences Com Shs (PMN)
First Tracks Biotherapeutics Ord Shs (TRAX)
Axsome Therapeutics (AXSM)
Assembly Biosciences Com New (ASMB)
Aadi Bioscience (WHWK)
Edgewise Therapeutics (EWTX)
Eliem Therapeutics (CLYM)
Kura Oncology (KURA)
Cytomx Therapeutics (CTMX)
Avalo Therapeutics Sponsored Ads (AVTX)
Palisade Bio (PALI)
Solid Biosciences (SLDB)

View all positions for Ally Bridge Group

Top funds holding First Tracks Biotherapeutics

FMR
Affinity Asset Advisors
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Sanofi
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Arrowstreet Capital, Limited Partnership
Federated Investors
Ally Bridge Group

View all funds holding First Tracks Biotherapeutics